Recalls / Active ingredient / Benralizumab
Benralizumab
1 FDA drug recall involving the active ingredient “Benralizumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-10-08 | Class II | Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: Astr | ASTRAZENECA PHARMACEUTICALS |